@phdthesis{Goetze2018, author = {G{\"o}tze, Michael Jan Werner}, title = {Aktuelle Fragen der strafrechtlichen Providerhaftung insbesondere zur Haftung des Access-Providers}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-156386}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2018}, abstract = {Dieses Werk widmet sich der Frage der strafrechtlichen Haftung von Internetprovidern und geht schwerpunktm{\"a}ßig auf die spezielle Haftung des Access-Providers ein.}, language = {de} } @article{WernerSchmidHiguchietal.2018, author = {Werner, Rudolf and Schmid, Jan-Stefan and Higuchi, Takahiro and Javadi, Mehrbod S. and Rowe, Steven P. and M{\"a}rkl, Bruno and Aulmann, Christoph and Fassnacht, Martin and Kroiß, Matthias and Reiners, Christoph and Buck, Andreas and Kreissl, Michael and Lapa, Constantin}, title = {Predictive value of \(^{18}\)F-FDG PET in patients with advanced medullary thyroid carcinoma treated with vandetanib}, series = {Journal of Nuclear Medicine}, journal = {Journal of Nuclear Medicine}, issn = {0161-5505}, doi = {10.2967/jnumed.117.199778}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-161256}, year = {2018}, abstract = {Introduction: Therapeutic options in advanced medullary thyroid carcinoma (MTC) have markedly improved since the introduction of tyrosine kinase inhibitors (TKI). We aimed to assess the role of metabolic imaging using 2-deoxy-2-(\(^{18}\)F)fluoro-D-glucose (\(^{18}\)F-FDG) positron emission tomography/computed tomography (PET/CT) shortly before and 3 months after initiation of TKI treatment. Methods: Eighteen patients with advanced and progressive MTC scheduled for vandetanib treatment underwent baseline \(^{18}\)F-FDG PET/CT prior to and 3 months after TKI treatment initiation. During follow-up, CT scans were performed every 3 months and analyzed according to Response Evaluation Criteria In Solid Tumors (RECIST). The predictive value for estimating progression-free (PFS) and overall survival (OS) was examined by investigating \(^{18}\)F-FDG mean/maximum standardized uptake values (SUVmean/max) of the metabolically most active lesion as well as by analyzing clinical parameters (tumor marker doubling times {calcitonin, carcinoembryonic antigen (CEA)}, prior therapies, RET (rearranged during transfection) mutational status, and disease type). Results: Within a median follow-up of 5.2 years, 9 patients experienced disease progression after a median time interval of 2.1y whereas the remainder had ongoing disease control (n=5 partial response and n=4 stable disease). Eight of the 9 patients with progressive disease died from MTC after a median of 3.5y after TKI initiation. Pre-therapeutic SUVmean >4.0 predicted a significantly shorter PFS (PFS: 1.9y vs. 5.2y; p=0.04). Furthermore, sustained high 18F-FDG uptake at 3 months with a SUVmean>2.8 tended to portend an unfavorable prognosis with a PFS of 1.9y (vs. 3.5y; p=0.3). Prolonged CEA doubling times were significantly correlated with longer PFS (r=0.7) and OS (r=0.76, p<0.01, respectively). None of the other clinical parameters had prognostic significance. Conclusions: Pre-therapeutic \(^{18}\)F-FDG PET/CT holds prognostic information in patients with advanced MTC scheduled for treatment with the TKI vandetanib. Low tumor metabolism of SUVmean < 4.0 prior to treatment predicts longer progression-free survival.}, subject = {Medull{\"a}rer Schilddr{\"u}senkrebs}, language = {en} } @article{WernerWeichHiguchietal.2017, author = {Werner, Rudolf A. and Weich, Alexander and Higuchi, Takahiro and Schmid, Jan S. and Schirbel, Andreas and Lassmann, Michael and Wild, Vanessa and Rudelius, Martina and Kudlich, Theodor and Herrmann, Ken and Scheurlen, Michael and Buck, Andreas K. and Kropf, Saskia and Wester, Hans-J{\"u}rgen and Lapa, Constantin}, title = {Imaging of Chemokine Receptor 4 Expression in Neuroendocrine Tumors - a Triple Tracer Comparative Approach}, series = {Theranostics}, volume = {7}, journal = {Theranostics}, number = {6}, doi = {10.7150/thno.18754}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-158008}, pages = {1489-1498}, year = {2017}, abstract = {C-X-C motif chemokine receptor 4 (CXCR4) and somatostatin receptors (SSTR) are overexpressed in gastro-entero-pancreatic neuroendocrine tumors (GEP-NET). In this study, we aimed to elucidate the feasibility of non-invasive CXCR4 positron emission tomography/computed tomography (PET/CT) imaging in GEP-NET patients using [\(^{68}\)Ga]Pentixafor in comparison to \(^{68}\)Ga-DOTA-D-Phe-Tyr3-octreotide ([\(^{68}\)Ga]DOTATOC) and \(^{18}\)F-fluorodeoxyglucose ([\(^{18}\)F]FDG). Twelve patients with histologically proven GEP-NET (3xG1, 4xG2, 5xG3) underwent [\(^{68}\)Ga]DOTATOC, [\(^{18}\)F]FDG, and [\(^{68}\)Ga]Pentixafor PET/CT for staging and planning of the therapeutic management. Scans were analyzed on a patient as well as on a lesion basis and compared to immunohistochemical staining patterns of CXCR4 and somatostatin receptors SSTR2a and SSTR5. [\(^{68}\)Ga]Pentixafor visualized tumor lesions in 6/12 subjects, whereas [\(^{18}\)F]FDG revealed sites of disease in 10/12 and [\(^{68}\)Ga]DOTATOC in 11/12 patients, respectively. Regarding sensitivity, SSTR-directed PET was the superior imaging modality in all G1 and G2 NET. CXCR4-directed PET was negative in all G1 NET. In contrast, 50\% of G2 and 80\% of G3 patients exhibited [\(^{68}\)Ga]Pentixafor-positive tumor lesions. Whereas CXCR4 seems to play only a limited role in detecting well-differentiated NET, increasing receptor expression could be non-invasively observed with increasing tumor grade. Thus, [\(^{68}\)Ga]Pentixafor PET/CT might serve as non-invasive read-out for evaluating the possibility of CXCR4-directed endoradiotherapy in advanced dedifferentiated SSTR-negative tumors.}, subject = {Positronen-Emissions-Tomografie}, language = {en} } @phdthesis{Werner2014, author = {Werner, Jan}, title = {Numerical Simulations of Heavy Fermion Systems: From He-3 Bilayers to Topological Kondo Insulators}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-112039}, school = {Universit{\"a}t W{\"u}rzburg}, year = {2014}, abstract = {Even though heavy fermion systems have been studied for a long time, a strong interest in heavy fermions persists to this day. While the basic principles of local moment formation, Kondo effect and formation of composite quasiparticles leading to a Fermi liquid, are under- stood, there remain many interesting open questions. A number of issues arise due to the interplay of heavy fermion physics with other phenomena like magnetism and superconduc- tivity. In this regard, experimental and theoretical investigations of He-3 can provide valuable insights. He-3 represents a unique realization of a quantum liquid. The fermionic nature of He-3 atoms, in conjunction with the absence of long-range Coulomb repulsion, makes this material an ideal model system to study Fermi liquid behavior. Bulk He-3 has been investigated for quite some time. More recently, it became possible to prepare and study layered He-3 systems, in particular single layers and bilayers. The pos- sibility of tuning various physical properties of the system by changing the density of He-3 and using different substrate materials makes layers of He-3 an ideal quantum simulator for investigating two-dimensional Fermi liquid phenomenology. In particular, bilayers of He-3 have recently been found to exhibit heavy fermion behavior. As a function of temperature, a crossover from an incoherent state with decoupled layers to a coherent Fermi liquid of composite quasiparticles was observed. This behavior has its roots in the hybridization of the two layers. The first is almost completely filled and subject to strong correlation effects, while the second layer is only partially filled and weakly correlated. The quasiparticles are formed due to the Kondo screening of localized moments in the first layer by the second-layer delocalized fermions, which takes place at a characteristic temperature scale, the coherence scale Tcoh. Tcoh can be tuned by changing the He-3 density. In particular, at a certain critical filling, the coherence scale is expected to vanish, corresponding to a divergence of the quasiparticle effective mass, and a breakdown of the Kondo effect at a quantum critical point. Beyond the critical point, the layers are decoupled. The first layer is a local moment magnet, while the second layer is an itinerant overlayer. However, already at a filling smaller than the critical value, preempting the critical point, the onset of a finite sample magnetization was observed. The character of this intervening phase remained unclear. Motivated by these experimental observations, in this thesis the results of model calcula- tions based on an extended Periodic Anderson Model are presented. The three particle ring exchange, which is the dominant magnetic exchange process in layered He-3, is included in the model. It leads to an effective ferromagnetic interaction between spins on neighboring sites. In addition, the model incorporates the constraint of no double occupancy by taking the limit of large local Coulomb repulsion. By means of Cellular DMFT, the model is investigated for a range of values of the chemical potential µ and inverse temperature β = 1/T . The method is a cluster extension to the Dy- namical Mean-Field Theory (DMFT), and allows to systematically include non-local correla- tions beyond the DMFT. The auxiliary cluster model is solved by a hybridization expansion CTQMC cluster solver, which provides unbiased, numerically exact results for the Green's function and other observables of interest. As a first step, the onset of Fermi liquid coherence is studied. At low enough temperature, the self-energy is found to exhibit a linear dependence on Matsubara frequency. Meanwhile, the spin susceptibility crossed over from a Curie-Weiss law to a Pauli law. Both observations serve as fingerprints of the Fermi liquid state. The heavy fermion state appears at a characteristic coherence scale Tcoh. This scale depends strongly on the density. While it is rather high for small filling, for larger filling Tcoh is increas- ingly suppressed. This involves a decreasing quasiparticle residue Z ∼ Tcoh and an enhanced mass renormalization m∗/m ∼ Tcoh-1. Extrapolation leads to a critical filling, where the co- herence scale is expected to vanish at a quantum critical point. At the same time, the effective mass diverges. This corresponds to a breakdown of the Kondo effect, which is responsible for the formation of quasiparticles, due to a vanishing of the effective hybridization between the layers. Taking only single-site DMFT results into account, the above scenario seems plausible. However, paramagnetic DMFT neglects the ring exchange interaction completely. In or- der to improve on this, Cellular DMFT simulations are conducted for small clusters of size Nc = 2 and 3. The results paint a different physical picture. The ring exchange, by favor- ing a ferromagnetic alignment of spins, competes with the Kondo screening. As a result, strong short-range ferromagnetic fluctuations appear at larger values of µ. By lowering the temperature, these fluctuations are enhanced at first. However, for T < Tcoh they are increas- ingly suppressed, which is consistent with Fermi liquid coherence. However, beyond a certain threshold value of µ, fluctuations persist to the lowest temperatures. At the same time, while not apparent in the DMFT results, the total occupation n increases quite strongly in a very narrow range around the same value of µ. The evolution of n with µ is always continuous, but hints at a discontinuity in the limit Nc → ∞. This first-order transition breaks the Kondo effect. Beyond the transition, a ferromagnetic state in the first layer is established, and the second layer becomes a decoupled overlayer. These observations provide a quite appealing interpretation of the experimental results. As a function of chemical potential, the Kondo breakdown quantum critical point is preempted by a first-order transition, where the layers decouple and the first layer turns into a ferromagnet. In the experimental situation, where the filling can be tuned directly, the discontinuous transition is mirrored by a phase separation, which interpolates between the Fermi liquid ground state at lower filling and the magnetic state at higher filling. This is precisely the range of the intervening phase found in the experiments, which is characterized by an onset of a finite sample magnetization. Besides the interplay of heavy fermion physics and magnetic exchange, recently the spin- orbit coupling, which is present in many heavy fermion materials, attracted a lot of interest. In the presence of time-reversal symmetry, due to spin-orbit coupling, there is the possibility of a topological ground state. It was recently conjectured that the energy scale of spin-orbit coupling can become dom- inant in heavy fermion materials, since the coherence scale and quasiparticle bandwidth are rather small. This can lead to a heavy fermion ground state with a nontrivial band topology; that is, a topological Kondo insulator (TKI). While being subject to strong correlation effects, this state must be adiabatically connected to a non-interacting, topological state. The idea of the topological ground state realized in prototypical Kondo insulators, in par- ticular SmB6, promises to shed light on some of the peculiarities of these materials, like a residual conductivity at the lowest temperatures, which have remained unresolved so far. In this work, a simple two-band model for two-dimensional topological Kondo insulators is devised, which is based on a single Kramer's doublet coupled to a single conduction band. The model is investigated in the presence of a Hubbard interaction as a function of interaction strength U and inverse temperature β. The bulk properties of the model are obtained by DMFT, with a hybridization expansion CTQMC impurity solver. The DMFT approximation of a local self-energy leads to a very simple way of computing the topological invariant. The results show that with increasing U the system can be driven through a topological phase transition. Interestingly, the transition is between distinct topological insulating states, namely the Γ-phase and M-phase. This appearance of different topological phases is possible due to the symmetry of the underlying square lattice. By adiabatically connecting both in- teracting states with the respective non-interacting state, it is shown that the transition indeed drives the system from the Γ-phase to the M-phase. A different behavior can be observed by pushing the bare position of the Kramer's doublet to higher binding energies. In this case, the non-interacting starting point has a trivial band topology. By switching on the interaction, the system can be tuned through a quantum phase transition, with a closing of the band gap. Upon reopening of the band gap, the system is in the Γ-phase, i. e. a topological insulator. By increasing the interaction strength further, the system moves into a strongly correlated regime. In fact, close to the expected transition to the M phase, the mass renormalization becomes quite substantial. While absent in the para- magnetic DMFT simulations conducted, it is conceivable that instead of a topological phase transition, the system undergoes a time-reversal symmetry breaking, magnetic transition. The regime of strong correlations is studied in more detail as a function of temperature, both in the bulk and with open boundary conditions. A quantity which proved very useful is the bulk topological invariant Ns, which can be generalized to finite interaction strength and temperature. In particular, it can be used to define a temperature scale T ∗ for the onset of the topological state. Rescaling the results for Ns, a nice data collapse of the results for different values of U, from the local moment regime to strongly mixed valence, is obtained. This hints at T ∗ being a universal low energy scale in topological Kondo insulators. Indeed, by comparing T ∗ with the coherence scale extracted from the self-energy mass renormalization, it is found that both scales are equivalent up to a constant prefactor. Hence, the scale T ∗ obtained from the temperature dependence of topological properties, can be used as an independent measure for Fermi liquid coherence. This is particularly useful in the experimentally relevant mixed valence regime, where charge fluctuations cannot be neglected. Here, a separation of the energy scales related to spin and charge fluctuations is not possible. The importance of charge fluctuations becomes evident in the extent of spectral weight transfer as the temperature is lowered. For mixed valence, while the hybridization gap emerges, a substantial amount of spectral weight is shifted from the vicinity of the Fermi level to the lower Hubbard band. In contrast, this effect is strongly suppressed in the local moment regime. In addition to the bulk properties, the spectral function for open boundaries is studied as a function of temperature, both in the local moment and mixed valence regime. This allows an investigation of the emergence of topological edge states with temperature. The method used here is the site-dependent DMFT, which is a generalization of the conventional DMFT to inhomogeneous systems. The hybridization expansion CTQMC algorithm is used as impurity solver. By comparison with the bulk results for the topological quantity Ns, it is found that the temperature scale for the appearance of the topological edge states is T ∗, both in the mixed valence and local moment regime.}, subject = {Fermionensystem}, language = {en} } @article{HolzapfelChhayaMelchelsetal.2013, author = {Holzapfel, Boris Michael and Chhaya, Mohit Prashant and Melchels, Ferry Petrus Wilhelmus and Holzapfel, Nina Pauline and Prodinger, Peter Michael and von Eisenhart-Rothe, R{\"u}diger and Griensven, Martijn van and Schantz, Jan-Thorsten and Rudert, Maximilian and Hutmacher, Dietmar Werner}, title = {Can Bone Tissue Engineering Contribute to Therapy Concepts after Resection of Musculoskeletal Sarcoma?}, series = {Sarcoma}, volume = {2013}, journal = {Sarcoma}, number = {Article ID 153640}, doi = {10.1155/2013/153640}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-132465}, pages = {10 p.}, year = {2013}, abstract = {Resection of musculoskeletal sarcoma can result in large bone defects where regeneration is needed in a quantity far beyond the normal potential of self-healing. In many cases, these defects exhibit a limited intrinsic regenerative potential due to an adjuvant therapeutic regimen, seroma, or infection. Therefore, reconstruction of these defects is still one of the most demanding procedures in orthopaedic surgery. The constraints of common treatment strategies have triggered a need for new therapeutic concepts to design and engineer unparalleled structural and functioning bone grafts. To satisfy the need for long-term repair and good clinical outcome, a paradigm shift is needed from methods to replace tissues with inert medical devices to more biological approaches that focus on the repair and reconstruction of tissue structure and function. It is within this context that the field of bone tissue engineering can offer solutions to be implemented into surgical therapy concepts after resection of bone and soft tissue sarcoma. In this paper we will discuss the implementation of tissue engineering concepts into the clinical field of orthopaedic oncology.}, language = {en} } @article{JeanclosSchloetzerHadameketal.2022, author = {Jeanclos, Elisabeth and Schl{\"o}tzer, Jan and Hadamek, Kerstin and Yuan-Chen, Natalia and Alwahsh, Mohammad and Hollmann, Robert and Fratz, Stefanie and Yesilyurt-Gerhards, Dilan and Frankenbach, Tina and Engelmann, Daria and Keller, Angelika and Kaestner, Alexandra and Schmitz, Werner and Neuenschwander, Martin and Hergenr{\"o}der, Roland and Sotriffer, Christoph and von Kries, Jens Peter and Schindelin, Hermann and Gohla, Antje}, title = {Glycolytic flux control by drugging phosphoglycolate phosphatase}, series = {Nature Communications}, volume = {13}, journal = {Nature Communications}, number = {1}, doi = {10.1038/s41467-022-34228-2}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-300928}, year = {2022}, abstract = {Targeting the intrinsic metabolism of immune or tumor cells is a therapeutic strategy in autoimmunity, chronic inflammation or cancer. Metabolite repair enzymes may represent an alternative target class for selective metabolic inhibition, but pharmacological tools to test this concept are needed. Here, we demonstrate that phosphoglycolate phosphatase (PGP), a prototypical metabolite repair enzyme in glycolysis, is a pharmacologically actionable target. Using a combination of small molecule screening, protein crystallography, molecular dynamics simulations and NMR metabolomics, we discover and analyze a compound (CP1) that inhibits PGP with high selectivity and submicromolar potency. CP1 locks the phosphatase in a catalytically inactive conformation, dampens glycolytic flux, and phenocopies effects of cellular PGP-deficiency. This study provides key insights into effective and precise PGP targeting, at the same time validating an allosteric approach to control glycolysis that could advance discoveries of innovative therapeutic candidates.}, language = {en} } @article{HarterHaukeHeitzetal.2017, author = {Harter, Philipp and Hauke, Jan and Heitz, Florian and Reuss, Alexander and Kommoss, Stefan and Marm{\´e}, Frederik and Heimbach, Andr{\´e} and Prieske, Katharina and Richters, Lisa and Burges, Alexander and Neidhardt, Guido and de Gregorio, Nikolaus and El-Balat, Ahmed and Hilpert, Felix and Meier, Werner and Kimmig, Rainer and Kast, Karin and Sehouli, Jalid and Baumann, Klaus and Jackisch, Christian and Park-Simon, Tjoung-Won and Hanker, Lars and Kr{\"o}ber, Sandra and Pfisterer, Jacobus and Gevensleben, Heidrun and Schnelzer, Andreas and Dietrich, Dimo and Neunh{\"o}ffer, Tanja and Krockenberger, Mathias and Brucker, Sara Y. and N{\"u}rnberg, Peter and Thiele, Holger and Altm{\"u}ller, Janine and Lamla, Josefin and Elser, Gabriele and du Bois, Andreas and Hahnen, Eric and Schmutzler, Rita}, title = {Prevalence of deleterious germline variants in risk genes including \(BRCA1/2\) in consecutive ovarian cancer patients (AGO-TR-1)}, series = {PLoS ONE}, volume = {12}, journal = {PLoS ONE}, number = {10}, doi = {10.1371/journal.pone.0186043}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-173553}, year = {2017}, abstract = {Background Identification of families at risk for ovarian cancer offers the opportunity to consider prophylactic surgery thus reducing ovarian cancer mortality. So far, identification of potentially affected families in Germany was solely performed via family history and numbers of affected family members with breast or ovarian cancer. However, neither the prevalence of deleterious variants in \(BRCA1/2\) in ovarian cancer in Germany nor the reliability of family history as trigger for genetic counselling has ever been evaluated. Methods Prospective counseling and germline testing of consecutive patients with primary diagnosis or with platinum-sensitive relapse of an invasive epithelial ovarian cancer. Testing included 25 candidate and established risk genes. Among these 25 genes, 16 genes (\(ATM\), \(BRCA1\), \(BRCA2\), \(CDH1\), \(CHEK2\), \(MLH1\), \(MSH2\), \(MSH6\), \(NBN\), \(PMS2\), \(PTEN\), \(PALB2\), \(RAD51C\), \(RAD51D\), \(STK11\), \(TP53\)) were defined as established cancer risk genes. A positive family history was defined as at least one relative with breast cancer or ovarian cancer or breast cancer in personal history. Results In total, we analyzed 523 patients: 281 patients with primary diagnosis of ovarian cancer and 242 patients with relapsed disease. Median age at primary diagnosis was 58 years (range 16-93) and 406 patients (77.6\%) had a high-grade serous ovarian cancer. In total, 27.9\% of the patients showed at least one deleterious variant in all 25 investigated genes and 26.4\% in the defined 16 risk genes. Deleterious variants were most prevalent in the \(BRCA1\) (15.5\%), \(BRCA2\) (5.5\%), \(RAD51C\) (2.5\%) and \(PALB2\) (1.1\%) genes. The prevalence of deleterious variants did not differ significantly between patients at primary diagnosis and relapse. The prevalence of deleterious variants in \(BRCA1/2\) (and in all 16 risk genes) in patients <60 years was 30.2\% (33.2\%) versus 10.6\% (18.9\%) in patients \(\geq\)60 years. Family history was positive in 43\% of all patients. Patients with a positive family history had a prevalence of deleterious variants of 31.6\% (36.0\%) versus 11.4\% (17.6\%) and histologic subtype of high grade serous ovarian cancer versus other showed a prevalence of deleterious variants of 23.2\% (29.1\%) and 10.2\% (14.8\%), respectively. Testing only for \(BRCA1/2\) would miss in our series more than 5\% of the patients with a deleterious variant in established risk genes. Conclusions 26.4\% of all patients harbor at least one deleterious variant in established risk genes. The threshold of 10\% mutation rate which is accepted for reimbursement by health care providers in Germany was observed in all subgroups analyzed and neither age at primary diagnosis nor histo-type or family history sufficiently enough could identify a subgroup not eligible for genetic counselling and testing. Genetic testing should therefore be offered to every patient with invasive epithelial ovarian cancer and limiting testing to \(BRCA1/2\) seems to be not sufficient.}, language = {en} } @article{WuZhaoHochreinetal.2023, author = {Wu, Hao and Zhao, Xiufeng and Hochrein, Sophia M. and Eckstein, Miriam and Gubert, Gabriela F. and Kn{\"o}pper, Konrad and Mansilla, Ana Maria and {\"O}ner, Arman and Doucet-Ladev{\`e}ze, Remi and Schmitz, Werner and Ghesqui{\`e}re, Bart and Theurich, Sebastian and Dudek, Jan and Gasteiger, Georg and Zernecke, Alma and Kobold, Sebastian and Kastenm{\"u}ller, Wolfgang and Vaeth, Martin}, title = {Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming}, series = {Nature Communications}, volume = {14}, journal = {Nature Communications}, doi = {10.1038/s41467-023-42634-3}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-358052}, year = {2023}, abstract = {T cell exhaustion is a hallmark of cancer and persistent infections, marked by inhibitory receptor upregulation, diminished cytokine secretion, and impaired cytolytic activity. Terminally exhausted T cells are steadily replenished by a precursor population (Tpex), but the metabolic principles governing Tpex maintenance and the regulatory circuits that control their exhaustion remain incompletely understood. Using a combination of gene-deficient mice, single-cell transcriptomics, and metabolomic analyses, we show that mitochondrial insufficiency is a cell-intrinsic trigger that initiates the functional exhaustion of T cells. At the molecular level, we find that mitochondrial dysfunction causes redox stress, which inhibits the proteasomal degradation of hypoxia-inducible factor 1α (HIF-1α) and promotes the transcriptional and metabolic reprogramming of Tpex cells into terminally exhausted T cells. Our findings also bear clinical significance, as metabolic engineering of chimeric antigen receptor (CAR) T cells is a promising strategy to enhance the stemness and functionality of Tpex cells for cancer immunotherapy.}, language = {en} } @article{SchofferSchueleinArandetal.2016, author = {Schoffer, Olaf and Sch{\"u}lein, Stefanie and Arand, Gerlinde and Arnholdt, Hans and Baaske, Dieter and Bargou, Ralf C. and Becker, Nikolaus and Beckmann, Matthias W. and Bodack, Yves and B{\"o}hme, Beatrix and Bozkurt, Tayfun and Breitsprecher, Regine and Buchali, Andre and Burger, Elke and Burger, Ulrike and Dommisch, Klaus and Elsner, Gudrun and Fernschild, Karin and Flintzer, Ulrike and Funke, Uwe and Gerken, Michael and G{\"o}bel, Hubert and Grobe, Norbert and Gumpp, Vera and Heinzerling, Lucie and Kempfer, Lana Raffaela and Kiani, Alexander and Klinkhammer-Schalke, Monika and Kl{\"o}cking, Sabine and Kreibich, Ute and Knabner, Katrin and Kuhn, Peter and Lutze, Stine and M{\"a}der, Uwe and Maisel, Tanja and Maschke, Jan and Middeke, Martin and Neubauer, Andreas and Niedostatek, Antje and Opazo-Saez, Anabelle and Peters, Christoph and Schell, Beatrice and Schenkirsch, Gerhard and Schmalenberg, Harald and Schmidt, Peter and Schneider, Constanze and Schubotz, Birgit and Seide, Anika and Strecker, Paul and Taubenheim, Sabine and Wackes, Matthias and Weiß, Steffen and Welke, Claudia and Werner, Carmen and Wittekind, Christian and Wulff, J{\"o}rg and Zettl, Heike and Klug, Stefanie J.}, title = {Tumour stage distribution and survival of malignant melanoma in Germany 2002-2011}, series = {BMC Cancer}, volume = {16}, journal = {BMC Cancer}, number = {936}, doi = {10.1186/s12885-016-2963-0}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-164544}, year = {2016}, abstract = {Background Over the past two decades, there has been a rising trend in malignant melanoma incidence worldwide. In 2008, Germany introduced a nationwide skin cancer screening program starting at age 35. The aims of this study were to analyse the distribution of malignant melanoma tumour stages over time, as well as demographic and regional differences in stage distribution and survival of melanoma patients. Methods Pooled data from 61 895 malignant melanoma patients diagnosed between 2002 and 2011 and documented in 28 German population-based and hospital-based clinical cancer registries were analysed using descriptive methods, joinpoint regression, logistic regression and relative survival. Results The number of annually documented cases increased by 53.2\% between 2002 (N = 4 779) and 2011 (N = 7 320). There was a statistically significant continuous positive trend in the proportion of stage UICC I cases diagnosed between 2002 and 2011, compared to a negative trend for stage UICC II. No trends were found for stages UICC III and IV respectively. Age (OR 0.97, 95\% CI 0.97-0.97), sex (OR 1.18, 95\% CI 1.11-1.25), date of diagnosis (OR 1.05, 95\% CI 1.04-1.06), 'diagnosis during screening' (OR 3.24, 95\% CI 2.50-4.19) and place of residence (OR 1.23, 95\% CI 1.16-1.30) had a statistically significant influence on the tumour stage at diagnosis. The overall 5-year relative survival for invasive cases was 83.4\% (95\% CI 82.8-83.9\%). Conclusions No distinct changes in the distribution of malignant melanoma tumour stages among those aged 35 and older were seen that could be directly attributed to the introduction of skin cancer screening in 2008. "}, language = {en} } @article{FroehlichSerflingHiguchietal.2021, author = {Fr{\"o}hlich, Matthias and Serfling, Sebastian and Higuchi, Takahiro and Pomper, Martin G. and Rowe, Steven P. and Schmalzing, Marc and Tony, Hans-Peter and Gernert, Michael and Strunz, Patrick-Pascal and Portegys, Jan and Schwaneck, Eva-Christina and Gadeholt, Ottar and Weich, Alexander and Buck, Andreas K. and Bley, Thorsten A. and Guggenberger, Konstanze V. and Werner, Rudolf A.}, title = {Whole-Body [\(^{18}\)F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease}, series = {Diagnostics}, volume = {11}, journal = {Diagnostics}, number = {11}, issn = {2075-4418}, doi = {10.3390/diagnostics11112073}, url = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-250227}, year = {2021}, abstract = {The 2-deoxy-d-[\(^{18}\)F]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) is widely utilized to assess the vascular and articular inflammatory burden of patients with a suspected diagnosis of rheumatic disease. We aimed to elucidate the impact of [\(^{18}\)F]FDG PET/CT on change in initially suspected diagnosis in patients at the time of the scan. Thirty-four patients, who had undergone [\(^{18}\)F]FDG PET/CT, were enrolled and the initially suspected diagnosis prior to [18F]FDG PET/CT was compared to the final diagnosis. In addition, a semi-quantitative analysis including vessel wall-to-liver (VLR) and joint-to-liver (JLR) ratios was also conducted. Prior to [\(^{18}\)F]FDG PET/CT, 22/34 (64.7\%) of patients did not have an established diagnosis, whereas in 7/34 (20.6\%), polymyalgia rheumatica (PMR) was suspected, and in 5/34 (14.7\%), giant cell arteritis (GCA) was suspected by the referring rheumatologists. After [\(^{18}\)F]FDG PET/CT, the diagnosis was GCA in 19/34 (55.9\%), combined GCA and PMR (GCA + PMR) in 9/34 (26.5\%) and PMR in the remaining 6/34 (17.6\%). As such, [\(^{18}\)F]FDG PET/CT altered suspected diagnosis in 28/34 (82.4\%), including in all unclear cases. VLR of patients whose final diagnosis was GCA tended to be significantly higher when compared to VLR in PMR (GCA, 1.01 ± 0.08 (95\%CI, 0.95-1.1) vs. PMR, 0.92 ± 0.1 (95\%CI, 0.85-0.99), p = 0.07), but not when compared to PMR + GCA (1.04 ± 0.14 (95\%CI, 0.95-1.13), p = 1). JLR of individuals finally diagnosed with PMR (0.94 ± 0.16, (95\%CI, 0.83-1.06)), however, was significantly increased relative to JLR in GCA (0.58 ± 0.04 (95\%CI, 0.55-0.61)) and GCA + PMR (0.64 ± 0.09 (95\%CI, 0.57-0.71); p < 0.0001, respectively). In individuals with a suspected diagnosis of rheumatic disease, an inflammatory-directed [\(^{18}\)F]FDG PET/CT can alter diagnosis in the majority of the cases, particularly in subjects who were referred because of diagnostic uncertainty. Semi-quantitative assessment may be helpful in establishing a final diagnosis of PMR, supporting the notion that a quantitative whole-body read-out may be useful in unclear cases.}, language = {en} }